<HTML>
<HEAD>
   <TITLE>Glossary</TITLE>
<META NAME="AUTHOR" CONTENT="William White">
</HEAD>
<BODY BGCOLOR="#FFFFFF">
<P><BR>
</P>

<P><BR>
</P>

<CENTER><A NAME="toc.16"></A></CENTER>

<H1><CENTER>16 &nbsp; Glossary</CENTER></H1>

<P><BR>
<BR>
</P>

<DL>
   <DT><A NAME=3HM></A><I>3HM</I></DT>
   
   <DD>3-hydroxymorphinan, a metabolite of DXM.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=3MM></A><I>3MM</I></DT>
   
   <DD>3-methoxymorphinan, a metabolite of DXM.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=AMPA></A><I>AMPA</I></DT>
   
   <DD>A subtype of ion channel excitatory amino acid receptors.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=APAP></A><I>APAP</I></DT>
   
   <DD>Acetaminophen / paracetamol.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="Agent Lemon"></A><I>Agent Lemon</I></DT>
   
   <DD>A process for extracting DXM from syrups into DXM citrate;
   also the DXM citrate extraction.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=CEV></A><I>CEV</I></DT>
   
   <DD>Closed-eye visuals.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=CNS></A><I>CNS</I></DT>
   
   <DD>Central nervous system.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=CYA></A><I>CYA</I></DT>
   
   <DD>Cover Your Ass.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=CYP></A><I>CYP</I></DT>
   
   <DD>Cytochrome P450.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=DEA></A><I>DEA</I></DT>
   
   <DD>Drug Enforcement Agency.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=DTG></A><I>DTG</I></DT>
   
   <DD>A sigma/NMDA ligand used in research.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=DXM></A><I>DXM</I></DT>
   
   <DD>Dextromethorphan.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=DXO></A><I>DXO</I></DT>
   
   <DD>Dextrorphan.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=DZ></A><I>DZ</I></DT>
   
   <DD>Dizocilpine (q.v.).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=EAA></A><I>EAA</I></DT>
   
   <DD>Excitatory Amino Acid.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=FAQ></A><I>FAQ</I></DT>
   
   <DD>Frequently Asked Question(s); also refers to a document
   answering those questions.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=GABA></A><I>GABA</I></DT>
   
   <DD>Gamma-Aminobutyric Acid, a neuroreceptor type and
   neurotransmitter.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=GHB></A><I>GHB</I></DT>
   
   <DD>Gamma-Hydroxy Butyrate.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=IM></A><I>IM</I></DT>
   
   <DD>Intramuscular.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=IP></A><I>IP</I></DT>
   
   <DD>Intraperitoneal.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=IUPAC></A><I>IUPAC</I></DT>
   
   <DD>International Union of Pure and Applied Chemistry.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=IV></A><I>IV</I></DT>
   
   <DD>Intravenous.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=LD50></A><I>LD50</I></DT>
   
   <DD>Lethal dose for 50% of a given population (usually lab rats).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=LTP></A><I>LTP</I></DT>
   
   <DD>Long-Term Potentiation (of synaptic weight).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="Lilliputian hallucinations"></A><I>Lilliputian
   hallucinations</I></DT>
   
   <DD>Sensations or hallucinations of mistaken size, where objects
   are either too large or too small, or both; occurs on
   dissociatives, during temporal lobe seizures, and high fever.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=MAOI></A><I>MAOI</I></DT>
   
   <DD>Monoamine Oxidase Inhibitor. A drug which inhibits the enzyme
   MAO.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=MDMA></A><I>MDMA</I></DT>
   
   <DD>Methylenedioxymethamphetamine (ecstasy).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=MK801></A><I>MK801</I></DT>
   
   <DD>Dizocilpine (q.v.).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=NAN></A><I>NAN</I></DT>
   
   <DD>NMDA Antagonist Neurotoxicity, i.e., neurotoxicity caused by
   blockade of NMDA receptors.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=NH4OH></A><I>NH4OH</I></DT>
   
   <DD>Ammonium hydroxide.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=NMDA></A><I>NMDA</I></DT>
   
   <DD>N-methyl-D-aspartate, a type of excitatory amino acid
   receptor.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=NRH></A><I>NRH</I></DT>
   
   <DD>NMDA Receptor Hypofunction, another term for NAN.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=NT></A><I>NT</I></DT>
   
   <DD>Neurotransmitter.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=NaOH></A><I>NaOH</I></DT>
   
   <DD>Sodium hydroxide (lye).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=OEV></A><I>OEV</I></DT>
   
   <DD>Open-eye visuals.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=OTC></A><I>OTC</I></DT>
   
   <DD>Over the Counter, i.e., a drug available without prescription
   on drugstore shelves.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=P450></A><I>P450</I></DT>
   
   <DD>Cytochrome P450, an enzyme family.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=PC></A><I>PC</I></DT>
   
   <DD>Posterior Cingulate.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=PCP></A><I>PCP</I></DT>
   
   <DD>1-(1-phenylcyclohexyl)piperidine, phencyclidine; a widely
   available illegal dissociative.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=PGP></A><I>PGP</I></DT>
   
   <DD>Pretty Good Privacy, an encryption scheme.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=PPA></A><I>PPA</I></DT>
   
   <DD>phenylpropanolamine, a decongestant.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=PPP></A><I>PPP</I></DT>
   
   <DD>A sigma/NMDA ligand used in research.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=RC></A><I>RC</I></DT>
   
   <DD>Retrosplenial Cortex.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=SWAG></A><I>SWAG</I></DT>
   
   <DD>Scientific Wild-Assed Guess.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=TCP></A><I>TCP</I></DT>
   
   <DD>A sigma/NMDA ligand used in research.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=THC></A><I>THC</I></DT>
   
   <DD>Tetrahydrocannabinol, the active ingredient in marijuana.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=Usenet></A><I>Usenet</I></DT>
   
   <DD>A "virtual network" of computers in which articles (documents)
   posted in a given newsgroup are propagated to all other computers.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=VGAC></A><I>VGAC</I></DT>
   
   <DD>Voltage-gated anion channel.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=VGCC></A><I>VGCC</I></DT>
   
   <DD>Voltage-gated cation channel.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=VGIC></A><I>VGIC</I></DT>
   
   <DD>Voltage-gated ion channel.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=WoD></A><I>WoD</I></DT>
   
   <DD>War on Drugs.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=YMMV></A><I>YMMV</I></DT>
   
   <DD>Your mileage may vary (i.e., your experiences may be different
   from those listed).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=acetaminophen></A><I>acetaminophen</I></DT>
   
   <DD>APAP, paracetamol; an over-the-counter painkiller which is
   toxic in high doses.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="acid-base extraction"></A><I>acid-base
   extraction</I></DT>
   
   <DD>A process for extracting desired chemicals (usually alkaloids)
   from unwanted impurities through the use of acids and bases to
   change the solubility of the desired chemicals in polar and
   nonpolar solvents (e.g., water and naptha).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=agonist></A><I>agonist</I></DT>
   
   <DD>Activator; an agonist at a given neuroreceptor activates that
   receptor.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=alkaline></A><I>alkaline</I></DT>
   
   <DD>Having a pH above 7; basic. Lye and baking soda are both
   alkaline.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=ammonia></A><I>ammonia</I></DT>
   
   <DD>Technically NH3, a gas, but "household ammonia" is actually
   ammonium hydroxide (q.v.).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="ammonium hydroxide"></A><I>ammonium
   hydroxide</I></DT>
   
   <DD>NH4OH; a basic solution of ammonia gas in water.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="amotivational syndrome"></A><I>amotivational
   syndrome</I></DT>
   
   <DD>A syndrome characterized by lack of motivation, apathy,
   lethargy, etc., and which may be linked to use of marijuana or
   other drugs (this is highly debatable).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=amphetamine></A><I>amphetamine</I></DT>
   
   <DD>Speed (though this usually refers to methamphetamine, q.v.). A
   potent stimulant used recreationally which is illegal in most
   countries.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=analgesic></A><I>analgesic</I></DT>
   
   <DD>A substance which relieves pain.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=angeldustin></A><I>angeldustin</I></DT>
   
   <DD>Endopsychosin (q.v.).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=antagonist></A><I>antagonist</I></DT>
   
   <DD>Blocker; an antagonist at a given receptor blocks or lowers
   the activity of that receptor.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=antihistamine></A><I>antihistamine</I></DT>
   
   <DD>A drug which blocks histamine, typically used to treat
   allergic reactions.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=aspartate></A><I>aspartate</I></DT>
   
   <DD>An excitatory amino acid.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=basic></A><I>basic</I></DT>
   
   <DD>Having a pH above 7; opposite of acidic.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=binding></A><I>binding</I></DT>
   
   <DD>site A location (on a receptor or other structure) where a
   given chemical attatches itself.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="biogenic amine"></A><I>biogenic amine</I></DT>
   
   <DD>A family of neurotransmitters (consisting of serotonin,
   acetylcholine, histamine, dopamine, and noradrenaline).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=blockade></A><I>blockade</I></DT>
   
   <DD>Blockage of.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=bupropion></A><I>bupropion</I></DT>
   
   <DD>An atypical antidepressant which blocks the reuptake of
   dopamine.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=chlorpheniramine></A><I>chlorpheniramine</I></DT>
   
   <DD>An antihistamine.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="competitive antagonist"></A><I>competitive
   antagonist</I></DT>
   
   <DD>An antagonist that works by competing with the
   neurotransmitter for the same binding site.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="cross-tolerance"></A><I>cross-tolerance</I></DT>
   
   <DD>A phenomenon in which tolerance to one drug induces tolerance
   to another; LSD and psilocybe mushrooms show cross-tolerance.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=cytochrome></A><I>cytochrome</I></DT>
   
   <DD>A type of enzyme.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=decongestant></A><I>decongestant</I></DT>
   
   <DD>A drug which relieves congestion.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=demethylation></A><I>demethylation</I></DT>
   
   <DD>Removal of a methyl group.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=dextromethorphan></A><I>dextromethorphan</I></DT>
   
   <DD>The subject of this text; a cough suppressant and
   dissociative.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=diphenhydramine></A><I>diphenhydramine</I></DT>
   
   <DD>An antihistamine.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=dissociation></A><I>dissociation</I></DT>
   
   <DD>As used in this text, refers to a condition by which certain
   mental functions are dissociated or "separated" from others, to
   varying degree; in particular refers to the dissociation of
   sensory input and emotion from consciousness and memory.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=dissociative></A><I>dissociative</I></DT>
   
   <DD>A sigma/NMDA ligand drug which induces dissociation; derives
   from "dissociative anaesthetic" (q.v.).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="dissociative anaesthetic"></A><I>dissociative
   anaesthetic</I></DT>
   
   <DD>A drug which induces anaesthesia via dissociation of the
   conscious mind from sensory input.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=dizocilpine></A><I>dizocilpine</I></DT>
   
   <DD>MK801, DZ; a dissociative.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=downregulation></A><I>downregulation</I></DT>
   
   <DD>A process in which the number or activity of receptors
   decreases, typically in response to abnormally high activity
   (e.g., from a drug).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=dysphoria></A><I>dysphoria</I></DT>
   
   <DD>The opposite of euphoria; a feeling of emotional or mental
   discomfort.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="ego annihilation"></A><I>ego annihilation</I></DT>
   
   <DD>The loss of sense of self-awareness and/or self-identity that
   occurs on many psychedelics.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="eidetic imagery"></A><I>eidetic imagery</I></DT>
   
   <DD>As used in this text, refers to abnormally vivid, often fully
   realistic, imagination.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=endopsychosin></A><I>endopsychosin</I></DT>
   
   <DD>A proposed endogenous (produced by the body) neurotransmitter
   or ligand for the sigma and NMDA open channel sites. The body's
   own PCP.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=enzyme></A><I>enzyme</I></DT>
   
   <DD>A chemical produced within the body which degrades or changes
   substances or increases the rate of a given reaction.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=ethnobotanical></A><I>ethnobotanical</I></DT>
   
   <DD>A plant used by humans; often refers to a drug plant.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="excitotoxic rebound"></A><I>excitotoxic
   rebound</I></DT>
   
   <DD>A process by which removal of a drug which suppresses neural
   activity causes a "rebound" during which too much neural activity
   occurs; during this rebound, neurons can suffer damage or die.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=excitotoxicity></A><I>excitotoxicity</I></DT>
   
   <DD>Toxicity to nerve cells and processes resulting from too much
   activity.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=expectorant></A><I>expectorant</I></DT>
   
   <DD>A drug which increases production of, and thins, the phlegm
   (mucus) production.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=finger></A><I>finger</I></DT>
   
   <DD>An Internet protocol which allows one to check a user's login
   information.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=flanging></A><I>flanging</I></DT>
   
   <DD>As used in this text, a phenomenon of sensory perception in
   which sensory data seems to be split up into obvious "frames",
   often with an echo effect. Nitrous oxide is well known for
   auditory flanging.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="free base"></A><I>free base</I></DT>
   
   <DD>The "free" base form of an alkaloid, i.e., not paired with an
   acid molecule. The free base (or freebase) form of an alkaloid can
   usually be vaporized and inhaled (this is called "freebasing" the
   drug).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="full agonist"></A><I>full agonist</I></DT>
   
   <DD>An agonist which fully activates a given receptor.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=gelcap></A><I>gelcap</I></DT>
   
   <DD>A capsule formed of a gel material, sometimes gelatin but
   commonly a synthetic polyvinylpyrrolidone polymer.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=glutamate></A><I>glutamate</I></DT>
   
   <DD>An excitatory amino acid; also a term for an excitatory amino
   acid receptor.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=guaifenesin></A><I>guaifenesin</I></DT>
   
   <DD>An expectorant.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=haloperidol></A><I>haloperidol</I></DT>
   
   <DD>An antipsychotic drug used to treat schizophrenia which also
   has sigma activity.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=harmaline></A><I>harmaline</I></DT>
   
   <DD>A plant-derived MAOI.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=harmine></A><I>harmine</I></DT>
   
   <DD>A plant-derived MAOI.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=hippocampus></A><I>hippocampus</I></DT>
   
   <DD>A seahorse-shaped formation in the limbic system which is
   involved in the storage of memory for intermediate periods and the
   consolidation of those memories into permanent form.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=histamine></A><I>histamine</I></DT>
   
   <DD>A neurotransmitter (in the brain; in the body, histamine
   initiates an allergic reaction).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=hypoxia></A><I>hypoxia</I></DT>
   
   <DD>Lack of oxygen.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="ion channel"></A><I>ion channel</I></DT>
   
   <DD>A structure which lets ions enter or leave a cell; ion
   channels are sometimes paired with neuroreceptors which open or
   close the channel depending on the presence of a neurotransmitter.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="ionotropic receptor"></A><I>ionotropic
   receptor</I></DT>
   
   <DD>An ion channel receptor.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="irreversible antagonist"></A><I>irreversible
   antagonist</I></DT>
   
   <DD>An antagonist which binds permanently with a receptor,
   effectively destroying it.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=ischemia></A><I>ischemia</I></DT>
   
   <DD>Cutoff of blood (typically due to artery blockage or damage).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=ketamine></A><I>ketamine</I></DT>
   
   <DD>A dissociative anaesthetic used in animals, children, and burn
   victims; also used recreationally.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=ligand></A><I>ligand</I></DT>
   
   <DD>A chemical which binds somewhere; e.g., a "sigma ligand" is a
   drug which binds to sigma receptors somewhere. Ligands can be
   agonists or antagonists (or neither).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=lye></A><I>lye</I></DT>
   
   <DD>Sodium hydroxide.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=meclizine></A><I>meclizine</I></DT>
   
   <DD>An anticholinergic (i.e., drug which blocks acetylcholine
   receptors) used to prevent or treat nausea.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=metabolism></A><I>metabolism</I></DT>
   
   <DD>Transformation of a chemical by the body; metabolism of a drug
   usually results in a form which can be more easily excreted.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=metabolite></A><I>metabolite</I></DT>
   
   <DD>A product of metabolism (transformation by the body) of
   another drug.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="metabotropic receptor"></A><I>metabotropic
   receptor</I></DT>
   
   <DD>A receptor where activation leads to some change in metabolic
   processes within the cell, rather than opening or closing of an
   ion channel (c.f. ionotropic receptor).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=methamphetamine></A><I>methamphetamine</I></DT>
   
   <DD>Speed, crank, crystal, etc., a potent and (in most countries)
   illegal stimulant.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=microsome></A><I>microsome</I></DT>
   
   <DD>Refers to one of several membrane-containing structures within
   a cell; there isn't one structure which is the "microsome", as the
   term refers to a fraction found after centrifuging a cell sample.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=nM></A><I>nM</I></DT>
   
   <DD>Nanomoles (or nanomolar); a measure of concentration.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=naloxone></A><I>naloxone</I></DT>
   
   <DD>An opiate receptor antagonist used to treate opiate overdoses.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=naptha></A><I>naptha</I></DT>
   
   <DD>A low boiling nonpolar fraction derived from petroleum
   distillation; typically includes pentane, hexane, heptane, and
   derivatives thereof.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=neuropeptide></A><I>neuropeptide</I></DT>
   
   <DD>A peptide (short chain of amino acids) neurotransmitter.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=neurotoxic></A><I>neurotoxic</I></DT>
   
   <DD>Toxic to neurons or neural processes.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="noncompetitive antagonist"></A><I>noncompetitive
   antagonist</I></DT>
   
   <DD>An antagonist at a given receptor which doesn't bind to the
   same site as the neurotransmitter (c.f., competitive antagonist).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=nootropic></A><I>nootropic</I></DT>
   
   <DD>Capable of enhancing mental function. "Smart drug".
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=noscapine></A><I>noscapine</I></DT>
   
   <DD>A cough suppressant derived from opium.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=pH></A><I>pH</I></DT>
   
   <DD>An indication of the acidity of alkalinity of a substance.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=paracetamol></A><I>paracetamol</I></DT>
   
   <DD>Acetaminopen (q.v.).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="partial agonist"></A><I>partial agonist</I></DT>
   
   <DD>An agonist which partially activates a given receptor; may
   behave as an antagonist in the presence of enough
   neurotransmitter.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=pentazocine></A><I>pentazocine</I></DT>
   
   <DD>An opiate with strong sigma agonist properties.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="perforant path"></A><I>perforant path</I></DT>
   
   <DD>One of the neural pathways in limbic system which carries
   hippocampal signals.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=pharmacokinetic></A><I>pharmacokinetic</I></DT>
   
   <DD>Refering to the metabolism of a given drug.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=pharmacological></A><I>pharmacological</I></DT>
   
   <DD>Refering to the action (including the neuroreceptor binding)
   of a given drug.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=phencyclidine></A><I>phencyclidine</I></DT>
   
   <DD>PCP; an illegal dissociative commonly available ("angel dust",
   "greens", "hog", etc.).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=phenyleprine></A><I>phenyleprine</I></DT>
   
   <DD>A decongestant typically found only with antihistamines.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=phenylpropanolamine></A><I>phenylpropanolamine</I></DT>
   
   <DD>A decongestant and appetite suppressant.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=phosphene></A><I>phosphene</I></DT>
   
   <DD>A light or pattern which appears in the field of vision with
   eyes closed (and occasionally open). Phosphenes seem to come from
   the back of the eyelids, but are actually a result of slight but
   harmless abnormalities in retinal and visual processing networks.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=photophobia></A><I>photophobia</I></DT>
   
   <DD>Literally "fear of light"; refers to discomfort from too much
   light.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=plateau></A><I>plateau</I></DT>
   
   <DD>As used in the FAQ, refers to a given dosage range of DXM in
   which the strength of the effects change but the character of the
   effects do not.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=polistirex></A><I>polistirex</I></DT>
   
   <DD>A time-release polymer compound.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=polyamine></A><I>polyamine</I></DT>
   
   <DD>A chemical with more than one amine group; the polyamine site
   on the NMDA receptor will bind with several polyamines.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=polymorphism></A><I>polymorphism</I></DT>
   
   <DD>Having multiple forms. Genetic polymorphism of an enzyme (such
   as P450) means that there are genetically based differences in
   forms of that receptor.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="posterior cingulate"></A><I>posterior
   cingulate</I></DT>
   
   <DD>The posterior (rear) region of the cingulate cortex, a
   distinct part of the cerebral cortex located in the temporal lobe.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=pseudoephedrine></A><I>pseudoephedrine</I></DT>
   
   <DD>A decongestant.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=psychedelic></A><I>psychedelic</I></DT>
   
   <DD>A drug eliciting or producing altered states of consciousness,
   mind, and/or perception.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=psychoactive></A><I>psychoactive</I></DT>
   
   <DD>Having effects on the mind.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=psychonaut></A><I>psychonaut</I></DT>
   
   <DD>Someone who explores consciousness, the mind, and "inner
   space" through the use of meditation, drugs, sensory deprivation,
   and other methods.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=psychotomimetic></A><I>psychotomimetic</I></DT>
   
   <DD>Literally, "psychosis mimicking". The "approved" medical term
   for any drug which has psychedelic effects (although not
   necessarily pleasant ones).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=receptor></A><I>receptor</I></DT>
   
   <DD>A structure on or inside a cell which receives a chemical
   signal.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=reregulation></A><I>reregulation</I></DT>
   
   <DD>A process in which the number or activity of receptors
   changes, typically in response to an abnormally high or low level
   of activity at that receptor. c.f., upregulation, downregulation.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="retrosplenial cortex"></A><I>retrosplenial
   cortex</I></DT>
   
   <DD>A section of the temporal cortex which is involved in limbic
   pathways and may be damaged by high doses of dissociatives.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=reuptake></A><I>reuptake</I></DT>
   
   <DD>The process by which used neurotransmitters are taken back
   into cells to be recycled or destroyed.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="self-titration"></A><I>self-titration</I></DT>
   
   <DD>Adjusting the dosage of a drug onesself to achieve a given
   effect. Cigarette smokers quickly become adept at self-titrating
   nicotine levels to maintain a particular level of nicotine in the
   blood and brain.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=sensorium></A><I>sensorium</I></DT>
   
   <DD>One's sensory environment.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="sodium hydroxide"></A><I>sodium hydroxide</I></DT>
   
   <DD>NaOH, lye. A base.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME="spontaneous memory"></A><I>spontaneous
   memory</I></DT>
   
   <DD>The sudden and unexpected recall of a memory episode.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=spoonerism></A><I>spoonerism</I></DT>
   
   <DD>Swapping the first letter or syllable of adjacent or
   near-adjacent words, often resulting in equally valid words, e.g.,
   "I made a spoonerism" to "I spade a moonerism".
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=sympathetic></A><I>sympathetic</I></DT>
   
   <DD>Referring to the subset of the peripheral nervous system
   activated in "fight or flight" behaviours.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=sympathomimetic></A><I>sympathomimetic</I></DT>
   
   <DD>Mimicking or potentiating sympathetic nervous system activity.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=synesthesia></A><I>synesthesia</I></DT>
   
   <DD>Perceiving sensory data of one sense with another, e.g.,
   seeing sounds or hearing colors.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=tachycardia></A><I>tachycardia</I></DT>
   
   <DD>Fast heart rate.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=tartrazine></A><I>tartrazine</I></DT>
   
   <DD>A dye commonly found in some cough syrups; some people are
   allergic to tartrazine.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=tetrodotoxin></A><I>tetrodotoxin</I></DT>
   
   <DD>An ion channel blocker; also the active ingredient in "zombie
   potion".
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=tryptophan></A><I>tryptophan</I></DT>
   
   <DD>An amino acid and the precursor to the neurotransmitter
   serotonin.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=tyrosine></A><I>tyrosine</I></DT>
   
   <DD>An amino acid and the precursor to the neurotransmitters
   dopamine and noradrenaline.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=upregulation></A><I>upregulation</I></DT>
   
   <DD>A process in which the number or activity of receptors
   increases, typically in response to abnormally low activity (e.g.,
   from an antagonist drug).
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=vasoconstriction></A><I>vasoconstriction</I></DT>
   
   <DD>Constriction of blood vessels.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=vasopressin></A><I>vasopressin</I></DT>
   
   <DD>A neuropeptide which has peripheral effects on blood vessels
   and kidney action, and which may also be a nootropic.
   
   <P>&nbsp;</P></DD>
   
   <DT><A NAME=vestibular></A><I>vestibular</I></DT>
   
   <DD>Refers to signals from the middle ear; vestibular sensations
   include floating, low-frequency vibrating, and similar
   sensations.</DD>
</DL>
</BODY>
</HTML>
